In the BioHarmony Drug Report Database
Inclisiran
Leqvio (inclisiran) is an oligonucleotide pharmaceutical. Inclisiran was first approved as Leqvio on 2020-12-09. It has been approved in Europe to treat dyslipidemias and hypercholesterolemia.
Trade Name
|
Leqvio |
|---|---|
Common Name
|
inclisiran |
ChEMBL ID
|
CHEMBL3990033 |
Indication
|
dyslipidemias, hypercholesterolemia |
Drug Class
|
Image (chem structure or protein)
